Mitochondrial dysfunction and hyperproliferation, orchestrated in part by the c-Myc–miR-17 axis, are major drivers of ADPKD, yet it remains unclear the extent to which PC1 restoration can directly reprogram these pathogenic processes [19–21]. Here, MYC is linked to autosomal dominant polycystic kidney disease.